The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk.
about
The APOA5 Trp19 allele is associated with metabolic syndrome via its association with plasma triglyceridesArchitectural roles of multiple chromatin insulators at the human apolipoprotein gene clusterRegulation of hepatic ApoC3 expression by PGC-1β mediates hypolipidemic effect of nicotinic acidAntiretroviral therapy and dyslipidaemia: unlocking the code.Apolipoprotein C3 gene variants and the risk of coronary heart disease: A meta-analysisProgress and prospects of long noncoding RNAs in lipid homeostasisPharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network studyAlterations in hepatic metabolism in fld mice reveal a role for lipin 1 in regulating VLDL-triacylglyceride secretion.Extension of GWAS results for lipid-related phenotypes to extreme obesity using electronic health record (EHR) data and the Metabochip.Data-Independent Acquisition and Parallel Reaction Monitoring Mass Spectrometry Identification of Serum Biomarkers for Ovarian Cancer.The expression of type III hyperlipoproteinemia: involvement of lipolysis genesInfluences of APOA5 variants on plasma triglyceride levels in Uyghur populationThe common apolipoprotein A-1 polymorphism -75A>G is associated with ethnic differences in recurrent coronary events after recovery from an acute myocardial infarction.The APOA1/C3/A4/A5 cluster and markers of allostatic load in the Boston Puerto Rican Health Study.The adsorption of biomolecules to multi-walled carbon nanotubes is influenced by both pulmonary surfactant lipids and surface chemistry.Complex interplay between the lipin 1 and the hepatocyte nuclear factor 4 α (HNF4α) pathways to regulate liver lipid metabolismThe dyslipidemia-associated SNP on the APOA1/C3/A5 gene cluster predicts post-surgery poor outcome in Taiwanese breast cancer patients: a 10-year follow-up studyHaplotype analysis of the Apolipoprotein A5 gene in Moroccan patients with the metabolic syndromeGenetic predisposition, nongenetic risk factors, and coronary infarct.Associations of the APOC3 rs5128 polymorphism with plasma APOC3 and lipid levels: a meta-analysisInteractions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome.Apolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease.Cerebrovascular atherosclerosis in type III hyperlipidemia is modulated by variation in the apolipoprotein A5 geneGenome-wide association study of triglyceride response to a high-fat meal among participants of the NHLBI Genetics of Lipid Lowering Drugs and Diet Network (GOLDN)The genetic architecture of fasting plasma triglyceride response to fenofibrate treatment.Apolipoprotein C3 polymorphisms, cognitive function and diabetes in Caribbean origin Hispanics.Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.Apolipoprotein A5 polymorphisms interact with total dietary fat intake in association with markers of metabolic syndrome in Puerto Rican older adults.Effects of variations in the APOA1/C3/A4/A5 gene cluster on different parameters of postprandial lipid metabolism in healthy young men.Genetic variants influencing circulating lipid levels and risk of coronary artery disease.Consumption of whole grains and legumes modulates the genetic effect of the APOA5 -1131C variant on changes in triglyceride and apolipoprotein A-V concentrations in patients with impaired fasting glucose or newly diagnosed type 2 diabetes.Pharmacogenomics of high-density lipoprotein-cholesterol-raising therapies.Detection of gene-environment interactions in a family-based population using SCAD.Two novel mutations in apolipoprotein C3 underlie atheroprotective lipid profiles in families.Apolipoprotein C-III inhibits triglyceride hydrolysis by GPIHBP1-bound LPL.Common variants APOC3, APOA5, APOE and PON1 are associated with variation in plasma lipoprotein traits in Greenlanders.Using primary murine intestinal enteroids to study dietary TAG absorption, lipoprotein synthesis, and the role of apoC-III in the intestine.Variants at the APOA5 locus, association with carotid atherosclerosis, and modification by obesity: the Framingham Study.Tendon Homeostasis in Hypercholesterolemia.Apolipoprotein A5: an emerging paradigm for genetic associations and interactions in lipoprotein and cardiovascular research
P2860
Q21261422-4A7699D5-2D12-44E5-8AED-66D114D03B07Q24309356-C5E46A3C-7FDC-46CD-B1B5-1A6CFB0AC8DCQ24594113-D355B8AA-313C-4C30-9963-AC83876CDA2FQ25256933-2A3432D4-C1E2-4FB9-A4D9-8A0D9E1E5301Q26743466-6DDA7075-E91D-4E36-A4B8-2E01DBC093A7Q26765495-1BA5AE3F-FE13-4A00-BB7D-F0DA7770C99BQ28302934-AB7D9A82-F3B9-46E8-9F5E-6FDAAF3A5B8CQ30439917-D243FB48-E57D-4EA0-9A55-8E496E0FCD24Q30844245-ADF3AB93-1C77-4BC6-9FE9-D02FE38813B0Q33773348-8E951F68-484B-4907-AEE0-D2B428E37D72Q34326186-9134FE27-DF9C-42D8-A1B9-6403CC76DBAEQ34338496-EC572863-22FA-4C1A-A255-A746337B49BFQ34383825-18D72ACE-B391-428B-85CF-32C3A1A92886Q34415298-60E2A2B4-524B-429B-B9B9-2A03396CEA7BQ34447943-8661615F-E2EA-40CC-9D46-CBD9E357981BQ34510859-A495F248-04A6-436C-BE3F-0349BC69BCB5Q34799703-9F88E117-BA2E-4B12-A619-75A914404160Q35532345-F2F9471A-D0E1-4BCA-88E4-403BF4626D7BQ35592025-4AA37D97-5DE1-4EFC-A919-BE2E8867A627Q35687045-81322544-C9DA-4824-913B-3590BB0E6D2EQ35908368-FA254784-19E6-496E-9ED1-696A2E1DBAF0Q35915137-EE462157-D4FB-4638-AE39-DA74EA144B9FQ35963956-53803943-6AA7-4160-8550-AF39F53F2832Q36068779-45A6884B-7B68-43EC-97F6-3C56E6038B69Q36897732-D976064D-CEE9-4513-BF76-6D9CE40195B1Q37173644-778F4840-0AAD-4491-B77C-E6134AC007F1Q37314809-46ADF3B5-3C27-4CD0-8042-F53A25F80C42Q37421221-339FC5B6-4786-4FF5-8E08-7D4665E0DB01Q37463331-1733964E-B625-47F2-AFA7-F8A7C0E3C47AQ37477713-1540E2FA-A571-4E18-B5F5-59922EF42E3EQ37682045-44B9DB72-12E7-4628-ABBB-0EEC5402E574Q37695401-DA8CF7FE-5E1F-4C89-AB16-0E327BB8FF62Q38679643-64C0D6E8-A8AA-42A8-9002-A95B02C5613FQ46281858-43E52DF3-DF4F-4D40-ABE5-981503F68CB0Q46300109-1A4A3639-A749-46D0-86FE-9348FF379FF1Q46754557-143A5468-A230-4112-8019-299CD7957167Q51153525-3325BD4F-F7DE-47AA-B959-A82830BC49F7Q51503282-163A2107-DD3B-437F-AAEA-F79DC151D44FQ51565496-201F91FC-7D3D-420C-B0F5-E1FDF3F4C8F9Q57336937-CE67C0A3-7EEF-4340-B70D-744D7F4777F0
P2860
The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk.
@ast
The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk.
@en
type
label
The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk.
@ast
The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk.
@en
prefLabel
The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk.
@ast
The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk.
@en
P1476
The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk
@en
P2093
Chao-Qiang Lai
Jose M Ordovas
P304
P356
10.1097/01.MOL.0000162320.54795.68
P577
2005-04-01T00:00:00Z